Companies & Products

BREXOGEN INC

Posted on by admin
At Brexogen, we are developing biomacromolecule cargo-controlled exosome as a cell-free regenerative medicine. By using induced pluripotent stem cells derived mesenchymal stem cells and stem cell stimulation technologies, we control the biomacromolecule cargo potential and composition inside exosome.
 

icon